Therapeutic & Specialty Expertise
-
Therapeutic Expertise
2/1/2022
Connect your clinical program with strong scientific and medical expertise, deep therapeutic insights, and unrivaled clinical trials experience to find the most direct route from breakthrough science to new therapies for patients.
-
Finding Value In Failing Trials
1/25/2022
Understand how losses from failed clinical trials can now be mitigated through the use of artificial intelligence (AI) and machine learning-driven platforms that identify sub-populations of patients within a clinical trial who could respond positively to a treatment.
-
Paving The Path In Haematological Cancers
3/22/2022
Explore the key developments in the haematological cancer space and the unique challenges and critical factors for success regarding the development and commercialization of assets for this type of cancer.
-
Navigating The Complex Realities Of Biomarker Testing In Oncology
3/22/2022
Gain insight into the rapidly evolving biomarker landscape in oncology, from clinical development to regulatory uncertainties to commercial implications, in this white paper.
-
Is Two Better Than One? Anti-PD1/PDL1 Combination Therapies Take Centre Stage
3/22/2022
Shifting away from the reliance on chemotherapies and radiation treatments, explore how immuno-oncology (IO), targeted therapies associated with predictive biomarkers, is increasingly becoming standard treatment.
-
Biomarker Testing In Oncology
3/22/2022
Biomarkers are indicators of a patient’s likelihood to respond to certain treatments. Learn how testing for predictive biomarkers can help oncologists make more informed treatment decisions.
-
A New Dawn: At The Cusp Of The CNS Decade
1/25/2022
This white paper explores the enablers of R&D breakthroughs in the treatment of neurological conditions, examines trends in how the pharmaceutical industry is embracing this momentous opportunity, and identifies critical success factors for central nervous system (CNS) innovators.